Nephros, Inc. (NEPH)
NASDAQ: NEPH · Real-Time Price · USD
3.860
-0.380 (-8.96%)
At close: Jun 27, 2025, 4:00 PM
3.770
-0.090 (-2.33%)
After-hours: Jun 27, 2025, 4:01 PM EDT
Nephros Market Cap
Nephros has a market cap or net worth of $40.92 million as of June 27, 2025. Its market cap has increased by 77.13% in one year.
Market Cap
40.92M
Enterprise Value
38.16M
1-Year Change
77.13%
Ranking
Category
Stock Price
$3.86
Market Cap Chart
Since August 15, 2019, Nephros's market cap has decreased from $54.10M to $40.92M, a decrease of -24.37%. That is a compound annual growth rate of -4.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 44.90M | 189.68% |
| Dec 31, 2024 | 15.50M | -57.30% |
| Dec 29, 2023 | 36.30M | 205.04% |
| Dec 30, 2022 | 11.90M | -80.30% |
| Dec 31, 2021 | 60.40M | -28.61% |
| Dec 31, 2020 | 84.60M | 6.82% |
| Dec 31, 2019 | 79.20M | 46.40% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |